The Open Journal of Physiology and Pharmacology is dedicated to maintaining the highest standards of integrity, transparency, and objectivity in scientific research and publication. This policy outlines the journal’s commitment to identifying, managing, and mitigating conflicts of interest to preserve the credibility and reliability of its published content.
A conflict of interest (COI) arises when personal, financial, or professional relationships could compromise—or appear to compromise—the objectivity, integrity, or impartiality of the research or publication process. Conflicts may involve authors, editors, reviewers, or any individuals participating in the preparation or evaluation of a manuscript.
Authors must disclose all potential conflicts of interest that could influence the research, interpretation, or presentation of their work. This includes financial relationships, institutional affiliations, consultancies, stock ownership, honoraria, paid expert testimony, or any other relevant associations.
All sources of funding, grants, or other financial support must be clearly identified in the manuscript. Transparent disclosure allows readers and reviewers to assess any potential influence of sponsors or funding agencies on the study’s outcomes.
When conflicts exist, authors should propose and implement appropriate steps to manage them—such as clear disclosure statements, acknowledgments of potential bias, or other measures that promote transparency and accountability.
Editors must assess all submissions based solely on their scientific quality, originality, and relevance. Editors must recuse themselves from handling a manuscript if they have any personal, financial, or professional relationship with the authors or the content that could affect impartiality.
Editorial decisions must be made independently of any external influences. If a conflict of interest is identified, an alternative editor or independent reviewer should be assigned to ensure fairness.
Editors are required to disclose any potential conflicts of interest and ensure that all editorial decisions are made transparently, maintaining trust in the editorial process.
Reviewers must evaluate manuscripts impartially and avoid any bias arising from personal, financial, or professional factors.
Reviewers should immediately inform the editorial office of any potential conflicts of interest. If a conflict is discovered after accepting a review invitation, the reviewer must notify the editor promptly to allow reassignment.
All manuscripts under review must be treated as confidential documents. Unpublished materials must not be used for personal advantage or shared with others.
The publisher of the Open Journal of Physiology and Pharmacology is committed to transparency in all aspects of journal operations. Any potential conflicts involving the publisher, editors, or other stakeholders will be disclosed promptly.
The publisher upholds the complete independence of the editorial team. Editorial decisions are based exclusively on the scholarly merit, originality, and relevance of submitted manuscripts, without influence from financial or institutional considerations.
When a conflict of interest is identified, the Open Journal of Physiology and Pharmacology will initiate a fair and transparent resolution process. This may include an internal review, consultation with relevant parties, and the implementation of corrective actions where necessary.
The editorial board actively participates in resolving conflicts of interest. In collaboration with relevant stakeholders, the board ensures that all resolutions are fair, unbiased, and consistent with the journal’s ethical standards.
The Open Journal of Physiology and Pharmacology provides ongoing training and resources to authors, editors, and reviewers to strengthen awareness and understanding of conflict of interest issues. These efforts foster a culture of ethical responsibility and transparency.
This policy is reviewed regularly to ensure continued effectiveness and alignment with international best practices in scholarly publishing. Any revisions will be communicated transparently to all stakeholders.